Discontinuation report PHENYLEPHRINE HYDROCHLORIDE INJECTION USP
| Report ID | 223140 |
| Drug Identification Number | 02504545 |
| Brand name | PHENYLEPHRINE HYDROCHLORIDE INJECTION USP |
| Common or Proper name | PHENYLEPHRINE HYDROCHLORIDE INJECTION USP |
| Company Name | STERIMAX INC |
| Market Status | MARKETED |
| Active Ingredient(s) | PHENYLEPHRINE HYDROCHLORIDE |
| Strength(s) | 10MG |
| Dosage form(s) | SOLUTION |
| Route of administration | SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR |
| Packaging size | 25 VIALS 1 ML |
| ATC code | C01CA |
| ATC description | CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | 2024-03-22 |
| Actual discontinuation date | |
| Remaining supply date | 2024-03-22 |
| Discontinuation status | To be discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | Product will no longer be available upon the depletion of inventory at the wholesalers. |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2770 PORTLAND DRIVE OAKVILLE, ONTARIO CANADA L6H 6R4 |
| Company contact information | 1-800-881-3550 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2024-03-22 | French | Compare |
| v1 | 2024-03-22 | English | Compare |
Showing 1 to 2 of 2